SOURCE: Research and Markets

Research and Markets

April 04, 2016 09:04 ET

Global Infusion Pumps & Accessories Market Assessment & Forecast: 2015-2019

Rising Population of Diabetes Coupled by Increasing Adoption of Insulin Pumps by Type II Diabetics

DUBLIN, IRELAND--(Marketwired - April 04, 2016) -  Research and Markets has announced the addition of the "Global Infusion Pumps & Accessories Market Assessment & Forecast: 2015-2019" report to their offering.

Chronic pain is a worldwide burden that is estimated to have a burden of over 600 billion dollars in United States alone, whereas cancer and diabetes have an annual burden of US$ 243.0 billion and US$ 188.0 billion.

Diabetes, cancer and chronic pain are long term illnesses that are increasing in incidence each year. In recent years the incidence and prevalence of diabetes has reached exponential levels with a global prevalence pegged by the WHO to be 9% worldwide among adults only. There is also a growing number of adolescent diabetes occurring worldwide.

The rising population of diabetes coupled by increasing adoption of insulin pumps by Type II diabetics will propel the market for these devices in coming years. Increasing number of trauma patients are opting for implantable infusion pumps or IBT therapies. The combined rise of diabetes, cancer and chronic pain will push the market for infusion pumps significantly through the forecast period and even beyond it.

With the advent of infusion pumps the medical community expected to reduce the number of errors, however even with all the medication administration errors, the single greatest source was human error. The most prominent disadvantage till recent times was that infusion pumps could not read the age, weight and other parameters of the patient from medical records in order to create filters and barriers for medication administration. The infusion pumps have to be programmed for use each time which have been causing massive errors where people have tragically died due to overdose of drugs. Close to 3 million people are estimated to rely on home infusions each year in United States alone and the trend is expected to be the same in Europe as well.

Increasing demand for healthcare services and products to be reached in patient comfort zones will continue in coming years driving the growth of the market. The Medicare Home Infusion Site of Care Act of 2015 provides a pathway for reimbursement for the professional services, supplies and equipment associated with infusion therapy in the home under Medicare Part B.

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Précis

Chapter 3 Market Dynamics

Chapter 4 Infusion Pumps & Accessories - Global Market Size Assessment, by Products, Forecast: 2015 - 2019

Chapter 5 Infusion Pumps - Global Market Size Assessment, by End-Users, Forecast: 2015 - 2019

Chapter 6 Infusion Pumps - Global Market Size Assessment, by Applications, Forecast: 2015 - 2019

Chapter 7 Infusion Pumps & Accessories - Global Market Size Assessment, by Geography, Forecast: 2015 - 2019

Chapter 8 Key Players Analysis: Infusion Pumps Market, 2014 (%)

  • 3AF Group
  • Akas Medical
  • Arcomed AG
  • Ascor SA
  • B Braun
  • Baxter
  • Caesarea Medical Electronics
  • CareFusion
  • Johnson & Johnson (Animas
  • KD Scientific
  • Medtronic Inc
  • Micrel Medical Devices
  • Mindray Medical
  • Moog Medical
  • Pancreum
  • Plenumtech
  • Roche
  • Schiller AG
  • Smiths Medical
  • Tandem
  • Tricumed
  • TSS Medical
  • Unilife
  • Zyno Medical

For more information visit

Sector: Infusions and Injectables

Contact Information

  • Research and Markets
    Laura Wood, Senior Manager

    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716